Sign Up

Novartis to buy Excellergy for up to $2 billion

RTE 1 min read 7 hours ago

Swiss pharma company Novartis said it will acquire California-based biotech company Excellergy in a deal worth up to $2 billion.
Read original RTE

More from RTE

Defeat will hurt Ireland players as much as 2009 - Doyle
Soccer Pod: Doyle and Treacy analyse frustrating defeat
RTÉ2 audience reached 1.6 million peak for Ireland game
RFU 'not in a discussion' with Ireland head coach Farrell

Related in Business

Supermarket dairy price cuts 'tone deaf' - farmers
Retail sales slipped in February, but up year-on-year
Euro zone bond yields high on energy disruption fears
Cyclone batters Australia's LNG straining global supply